Privacy Policy

Privacy Policy

Ampio Pharmaceuticals, Inc. respects the privacy of visitors to its website. We will not collect any personal information about you, unless you provide it. Certain domain information may be collected solely to monitor website usage and improve our website. If you choose to submit personal information to us, we will use it to respond to your inquiries. We will not provide or sell the information to others and will comply with all applicable laws regarding uses of personal information.

Learn More About:

Premature Ejaculation (PE)

Premature ejaculation is a distressing male sexual dysfunction that is more common than erectile dysfunction (ED) and has a major impact on the quality of life for men and their sexual partners.

Diabetic Retinopathy

A complication of diabetes mellitus that damages the retina in the eyes and leads to blindness

Diabetic Nephropathy

A progressive complication of diabetes mellitus that leads to end-stage renal disease (ESRD) requiring kidney transplantation or chronic dialysis

AMPE Stock Quote - delayed
Last Change
AMPE 2.67 Down 0.14 (4.98%)

Ampio News

05/14/2012 | Press Release

Ampio Pharmaceuticals Schedules 2012 Update Webcast

05/11/2012 | Press Release

Ampio Pharmaceuticals Reports Pre-IND Meeting With the FDA to Obtain Clinical Path Guidance for Ampion™ for the Treatment of Chronic Pain of Osteoarthritis of the Knee and Schedules May 16th Webcast to Update Shareholders

04/30/2012 | Press Release

Ampio Pharmaceuticals announces extended analysis of Ampion™ In the Knee (AIK) Study shows pain relief of osteoarthritis, 84 days after a single injection into the knee, is statistically significant

» See all Ampio news